Zobrazeno 1 - 10
of 28
pro vyhledávání: '"S W, Chapman"'
Autor:
S. W. Chapman, R. Bakshi, E. B. Smith, A. B. Bustamante, N. Tiraboschi-Foss, C. Opper, A. Restrepo, C. Kauffmann, Peter G. Pappas, R. Dietze, S. Emady-Azar
Publikováno v:
Mycoses. 47:62-68
The aim of this study was to evaluate the safety and efficacy of oral terbinafine (500 and 1000 mg day(-1)) in the treatment of cutaneous or lymphocutaneous sporotrichosis. A culture for Sporothrix schenckii was required for inclusion into this multi
Publikováno v:
Vadose Zone Journal. 2:116-137
Autor:
S W Chapman, C R Daniel rd
Publikováno v:
Infectious Disease Clinics of North America. 8:879-910
Fungal infection of the skin and subcutaneous tissue may result from either direct contact or inoculation injury (primary infection) or from hematogenous spread from a primary focus of disease (secondary infection). The parainfectious lesions of eryt
Autor:
S W, Chapman, P, Pappas, C, Kauffmann, E B, Smith, R, Dietze, N, Tiraboschi-Foss, A, Restrepo, A B, Bustamante, C, Opper, S, Emady-Azar, R, Bakshi
Publikováno v:
Mycoses. 47(1-2)
The aim of this study was to evaluate the safety and efficacy of oral terbinafine (500 and 1000 mg day(-1)) in the treatment of cutaneous or lymphocutaneous sporotrichosis. A culture for Sporothrix schenckii was required for inclusion into this multi
Publikováno v:
Southern Medical Journal. 86:225-227
As the case presented here illustrates, nocardiosis, like other infections in which cell-mediated immunity plays a large defensive role, can relapse after apparent cure and occasionally at times remote from the original infection. Although relapse in
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 30(4)
The recommendations for the treatment of sporotrichosis were derived primarily from multicenter, nonrandomized treatment trials, small retrospective series, and case reports; no randomized, comparative treatment trials have been reported. Most cases
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 30(4)
Guidelines for the treatment of blastomycosis are presented; these guidelines are the consensus opinion of an expert panel representing the National Institute of Allergy and Infectious Diseases Mycoses Study Group and the Infectious Diseases Society
Publikováno v:
Seminars in respiratory infections. 12(3)
In order to clarify the epidemiology and clinical spectrum of endemic blastomycosis, we reviewed the charts of 326 culture and/or histologically proven cases of blastomycosis in Mississippi from 1979 to 1988. Cases were dispersed throughout the state
Autor:
P G, Pappas, R W, Bradsher, C A, Kauffman, G A, Cloud, C J, Thomas, G D, Campbell, S W, Chapman, C, Newman, W E, Dismukes
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 25(2)
Recent clinical data suggest that fluconazole at daily doses of 200 to 400 mg for at least 6 months is moderately effective therapy for non-life-threatening blastomycosis. To examine the usefulness of higher doses of fluconazole therapy for this diso
Autor:
Catherine A. Marco, S. W. Chapman
Publikováno v:
Annals of Emergency Medicine. 62:S26